Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Industry Pushes FDA For Narrower Policy On NDI Notifications

This article was originally published in The Tan Sheet

Executive Summary

FDA's expectation for firms to file new dietary ingredient notifications for all supplements that contain new ingredients "is tantamount to a registration process," industry leaders argue.
Advertisement

Related Content

Food Safety And Rising Costs Top 2012 Challenges For Supplement Industry
Food Safety And Rising Costs Top 2012 Challenges For Supplement Industry
Trade Groups Should Encourage Supplement NDI Compliance – Fabricant
Trade Groups Should Encourage Supplement NDI Compliance – Fabricant
NDI Draft Guidance Comments In Brief
FDA Supplement Enforcement Priorities Go Beyond NDI Notification
CRN Pushes Budget Office To Seek FDA Review Of NDI Notification Costs
FDA NDI Notification Draft Guidance Contradicts Final Rule – Ullman
NDI Guidance Is “Radical Departure” From DSHEA; More Comment Time Needed – Attorney
NDI Guidance Is “Radical Departure” From DSHEA; More Comment Time Needed – Attorney

Topics

Advertisement
UsernamePublicRestriction

Register

PS105228

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel